ZA983250B - Polymer-platinum compounds. - Google Patents

Polymer-platinum compounds.

Info

Publication number
ZA983250B
ZA983250B ZA9803250A ZA983250A ZA983250B ZA 983250 B ZA983250 B ZA 983250B ZA 9803250 A ZA9803250 A ZA 9803250A ZA 983250 A ZA983250 A ZA 983250A ZA 983250 B ZA983250 B ZA 983250B
Authority
ZA
South Africa
Prior art keywords
polymer
platinum compounds
platinum
compound
backbone
Prior art date
Application number
ZA9803250A
Other languages
English (en)
Inventor
Ruth Duncan
Evagoras G Evagorou
Robert G Buckley
Elizabetta Gianasi
Original Assignee
Acces Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acces Pharmaceuticals Inc filed Critical Acces Pharmaceuticals Inc
Publication of ZA983250B publication Critical patent/ZA983250B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Electroplating And Plating Baths Therefor (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9803250A 1997-04-18 1998-04-17 Polymer-platinum compounds. ZA983250B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4474397P 1997-04-18 1997-04-18

Publications (1)

Publication Number Publication Date
ZA983250B true ZA983250B (en) 1998-10-18

Family

ID=21934085

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9803250A ZA983250B (en) 1997-04-18 1998-04-17 Polymer-platinum compounds.

Country Status (12)

Country Link
US (1) US5965118A (de)
EP (1) EP1009439B1 (de)
JP (2) JP4536165B2 (de)
AT (1) ATE230613T1 (de)
AU (1) AU736297B2 (de)
CA (1) CA2286091C (de)
DE (1) DE69810636T2 (de)
DK (1) DK1009439T3 (de)
ES (1) ES2194312T3 (de)
TW (1) TW509573B (de)
WO (1) WO1998047537A1 (de)
ZA (1) ZA983250B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100729015B1 (ko) 2000-01-04 2007-06-14 어섹스 팔마큐티칼스 인코포레이티드 N,o-아미도말로네이트 백금 착화합물
US7166733B2 (en) * 2000-01-04 2007-01-23 Access Pharmaceuticals, Inc. O,O'-Amidomalonate and N,O-Amidomalonate platinum complexes
AU2006222657B2 (en) * 2000-01-04 2009-01-15 Access Pharmaceuticals, Inc. N,O-amidomalonate platinum complexes
EP1315777B1 (de) 2000-09-06 2007-10-31 AP Pharma, Inc. Abbaubare polyacetal-polymere
SG92833A1 (en) 2001-03-27 2002-11-19 Sumitomo Chemical Co Polymeric light emitting substance and polymer light emitting device using the same
KR100484504B1 (ko) * 2001-09-18 2005-04-20 학교법인 포항공과대학교 쿠커비투릴 유도체를 주인 분자로서 포함하고 있는 내포화합물 및 이를 포함한 약제학적 조성물
WO2005002508A2 (en) * 2003-06-11 2005-01-13 Access Pharmaceuticals, Inc. Macromolecular platinum chelates
ATE465205T1 (de) 2005-12-05 2010-05-15 Nitto Denko Corp Polyglutamat-aminosäure-konjugate und verfahren
CN101730549B (zh) * 2007-05-09 2015-12-09 日东电工株式会社 与铂类药物结合的聚合物
BRPI0920655A2 (pt) * 2008-10-07 2019-07-09 Rexahn Pharmaceuticals, Inc. conjugados e hpma-docetaxel ou gencitabina e usos dos mesmos
KR101721865B1 (ko) * 2009-10-13 2017-04-03 렉산 파마슈티컬스, 인코포레이티드 항암제의 전달을 위한 폴리머 시스템
EP2743273A1 (de) * 2012-12-12 2014-06-18 Umicore AG & Co. KG Verfahren zur Herstellung wasserhaltiger Zubereitungen von Komplexen der Platingruppenmetalle

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS173846B1 (de) * 1974-04-23 1977-03-31
CS173849B1 (de) * 1974-04-25 1977-03-31
IL73972A0 (en) * 1984-12-31 1985-03-31 Yeda Res & Dev Agents based on platinum compounds
GB8500209D0 (en) * 1985-01-04 1985-02-13 Ceskoslovenska Akademie Ved Synthetic polymeric drugs
IN165717B (de) * 1986-08-07 1989-12-23 Battelle Memorial Institute
US4931553A (en) * 1988-05-11 1990-06-05 Gill Devinder S Platinum-polymer complexes and their use as antitumor agents
US5420105A (en) * 1988-09-23 1995-05-30 Gustavson; Linda M. Polymeric carriers for non-covalent drug conjugation
GB9017024D0 (en) * 1990-08-03 1990-09-19 Erba Carlo Spa New linker for bioactive agents
US5484584A (en) * 1990-10-02 1996-01-16 Board Of Regents, The University Of Texas System Therapeutic and diagnostic use of modified polymeric microcapsules
GB9026491D0 (en) * 1990-12-05 1991-01-23 Erba Carlo Spa Anthracycline-conjugates
GB9200247D0 (en) * 1992-01-07 1992-02-26 Erba Carlo Spa Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
GB9213077D0 (en) * 1992-06-19 1992-08-05 Erba Carlo Spa Polymerbound taxol derivatives
GB2270920B (en) * 1992-09-25 1997-04-02 Univ Keele Alginate-bioactive agent conjugates
KR0164460B1 (ko) * 1995-10-02 1999-03-20 김은영 고분자 백금 착화합물, 그의 제조방법 및 그를 유효성분으로 하는 항암제

Also Published As

Publication number Publication date
JP4536165B2 (ja) 2010-09-01
JP2010132685A (ja) 2010-06-17
US5965118A (en) 1999-10-12
AU736297B2 (en) 2001-07-26
CA2286091A1 (en) 1998-10-29
TW509573B (en) 2002-11-11
DE69810636D1 (de) 2003-02-13
ATE230613T1 (de) 2003-01-15
DE69810636T2 (de) 2003-11-06
EP1009439A1 (de) 2000-06-21
DK1009439T3 (da) 2003-05-05
ES2194312T3 (es) 2003-11-16
JP2001524098A (ja) 2001-11-27
WO1998047537A1 (en) 1998-10-29
CA2286091C (en) 2010-07-06
AU7102698A (en) 1998-11-13
EP1009439B1 (de) 2003-01-08

Similar Documents

Publication Publication Date Title
PT927150E (pt) Compostos de lipoxina e sua utilizacao no tratamento de doencas proliferativas celulares
DE69623927D1 (de) Russzusammensetzungen und verbesserte polymerzusammensetzungen
ZA983250B (en) Polymer-platinum compounds.
DE68900305D1 (de) Kammerbuegel und baum fuer sattel.
DE69518919D1 (de) Autoantikörper enthaltende zusammensetzung für tumorbehandlung und -vorbeugung
HUP0004655A3 (en) Modified alumoxane catalyst activator
DE59611481D1 (en) Chromatin-regulatorgene
CA2245066A1 (en) Zinc-phthalocyanines and corresponding conjugates, their preparation and use in photodynamic therapy and as diagnostic agents
KR0164938B1 (en) Acrylamide polymer and its use
NL194084B (nl) Roeten alsmede rubbersamenstellingen met dergelijke roeten.
MX9707570A (es) Utilizacion de agonistas de alta1l para el tratamiento de la incontinencia urinaria.
FI970990A7 (fi) Syövän toteaminen ja hoito
GR3031897T3 (en) Antifungal nail solution
CA2169381A1 (en) Enhanced cross-linking of natural tissues
EP0910380A4 (de) Substituierte benzyliden-indenyl-formamide, acetamide und propionamide
CA2290482A1 (en) Fructan containing composition for the prevention and treatment of colon cancer
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
DE69729768D1 (de) Herzschrittmacher mit Bestimmung des anaeroben Schwellwertes
AU2217397A (en) Phosphoramidates and phosphinic amides, their use to modulate the activity of endothelin
GB2324091A (en) Metalloproteinase inhibitors
ZA969647B (en) Treated carbonaceous compositions and improved polymer compositions
HUT51657A (en) Polymer compositions comprising waste rubber and/or waste leather as auxiliaries
WO1998047496A3 (en) Polymer-platinum compounds
EP0295717A3 (en) Composition based on fluoroelastomers and on modified olefinic polymers
ZA969586B (en) The use of cholinesterase inhibitors in the treatment of xerostomia